Regeneron Pharmaceuticals, Inc. - Stock Analysis

Biotechnology
Healthcare

Regeneron Pharmaceuticals, Inc.

REGN · US · NASDAQ

1125.72

USD

+12.37

(1.10%)

39.98

EPS
28.16

P/E
122B

MARKET CAP
0.00%

DIV YIELD

Ten CAP valuation

Operating Cash Flow

$

Capital Expenditures

$

% for Maintenance

%

Maintenance CapEx

$

Tax Provision

$

Shares Outstanding

#

Owner Earnings

$

Owner Earnings per Share

$

--

Margin Of Safety valuation

Current EPS

$

Future Growth Rate

%

Future PE

Minimum Accepatable Rate Of Return

%

Sticker Price:

--

MOS Price:

--